Tauroursodeoxycholic acid prevents retinal degeneration in transgenic P23H rats. 2011

Laura Fernández-Sánchez, and Pedro Lax, and Isabel Pinilla, and José Martín-Nieto, and Nicolás Cuenca
Department of Physiology, Genetics and Microbiology, Universidad de Alicante, CampusUniversitario San Vicente, Alicante, Spain.

OBJECTIVE To evaluate the preventive effect of tauroursodeoxycholic acid (TUDCA) on photoreceptor degeneration, synaptic connectivity and functional activity of the retina in the transgenic P23H rat, an animal model of autosomal dominant retinitis pigmentosa (RP). METHODS P23H line-3 rats were injected with TUDCA once a week from postnatal day (P)21 to P120, in parallel with vehicle-administered controls. At P120, functional activity of the retina was evaluated by electroretinographic (ERG) recording. The effects of TUDCA on the number, morphology, integrity, and synaptic connectivity of retinal cells were characterized by immunofluorescence confocal microscopy. RESULTS The amplitude of ERG a- and b-waves was significantly higher in TUDCA-treated animals under both scotopic and photopic conditions than in control animals. In the central area of the retina, TUDCA-treated P23H rats showed threefold more photoreceptors than control animals. The number of TUNEL-positive cells was significantly smaller in TUDCA-treated rats, in which photoreceptor morphology was preserved. Presynaptic and postsynaptic elements, as well as the synaptic contacts between photoreceptors and bipolar or horizontal cells, were preserved in TUDCA-treated P23H rats. Furthermore, in TUDCA-treated rat retinas, the number of both rod bipolar and horizontal cell bodies, as well as the density of their synaptic terminals in the outer plexiform layer, was greater than in control rats. CONCLUSIONS TUDCA treatment was capable of preserving cone and rod structure and function, together with their contacts with their postsynaptic neurons. The neuroprotective effects of TUDCA make this compound potentially useful for delaying retinal degeneration in RP.

UI MeSH Term Description Entries
D007274 Injections, Intraperitoneal Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall. Intraperitoneal Injections,Injection, Intraperitoneal,Intraperitoneal Injection
D012162 Retinal Degeneration A retrogressive pathological change in the retina, focal or generalized, caused by genetic defects, inflammation, trauma, vascular disease, or aging. Degeneration affecting predominantly the macula lutea of the retina is MACULAR DEGENERATION. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p304) Degeneration, Retinal,Degenerations, Retinal,Retinal Degenerations
D002756 Cholagogues and Choleretics Gastrointestinal agents that stimulate the flow of bile into the duodenum (cholagogues) or stimulate the production of bile by the liver (choleretic). Choleretics,Cholagogues,Cholagogues, Choleretics,Choleretics and Cholagogues,Hydrocholeretics
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004596 Electroretinography Recording of electric potentials in the retina after stimulation by light. Electroretinographies
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013655 Taurochenodeoxycholic Acid A bile salt formed in the liver by conjugation of chenodeoxycholate with taurine, usually as the sodium salt. It acts as detergent to solubilize fats in the small intestine and is itself absorbed. It is used as a cholagogue and choleretic. Chenodeoxycholyltaurine,Taurine Chenodeoxycholate,Taurochenodeoxycholate,Acid, Taurochenodeoxycholic,Chenodeoxycholate, Taurine
D017729 Presynaptic Terminals The distal terminations of axons which are specialized for the release of neurotransmitters. Also included are varicosities along the course of axons which have similar specializations and also release transmitters. Presynaptic terminals in both the central and peripheral nervous systems are included. Axon Terminals,Nerve Endings, Presynaptic,Synaptic Boutons,Synaptic Terminals,Axon Terminal,Bouton, Synaptic,Boutons, Synaptic,Ending, Presynaptic Nerve,Endings, Presynaptic Nerve,Nerve Ending, Presynaptic,Presynaptic Nerve Ending,Presynaptic Nerve Endings,Presynaptic Terminal,Synaptic Bouton,Synaptic Terminal,Terminal, Axon,Terminal, Presynaptic,Terminal, Synaptic,Terminals, Axon,Terminals, Presynaptic,Terminals, Synaptic
D051245 Retinal Bipolar Cells INTERNEURONS of the vertebrate RETINA containing two processes. They receive inputs from the RETINAL PHOTORECEPTOR CELLS and send outputs to the RETINAL GANGLION CELLS. The bipolar cells also make lateral connections in the retina with the RETINAL HORIZONTAL CELLS and with the AMACRINE CELLS. Bipolar Cells, Retinal,Bipolar Cell, Retinal,Cell, Retinal Bipolar,Cells, Retinal Bipolar,Retinal Bipolar Cell
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

Laura Fernández-Sánchez, and Pedro Lax, and Isabel Pinilla, and José Martín-Nieto, and Nicolás Cuenca
August 2018, Free radical biology & medicine,
Laura Fernández-Sánchez, and Pedro Lax, and Isabel Pinilla, and José Martín-Nieto, and Nicolás Cuenca
May 2002, Investigative ophthalmology & visual science,
Laura Fernández-Sánchez, and Pedro Lax, and Isabel Pinilla, and José Martín-Nieto, and Nicolás Cuenca
October 2019, Experimental eye research,
Laura Fernández-Sánchez, and Pedro Lax, and Isabel Pinilla, and José Martín-Nieto, and Nicolás Cuenca
April 2003, Experimental eye research,
Laura Fernández-Sánchez, and Pedro Lax, and Isabel Pinilla, and José Martín-Nieto, and Nicolás Cuenca
January 2011, PloS one,
Laura Fernández-Sánchez, and Pedro Lax, and Isabel Pinilla, and José Martín-Nieto, and Nicolás Cuenca
February 2018, Experimental eye research,
Laura Fernández-Sánchez, and Pedro Lax, and Isabel Pinilla, and José Martín-Nieto, and Nicolás Cuenca
May 2016, Journal of lipid research,
Laura Fernández-Sánchez, and Pedro Lax, and Isabel Pinilla, and José Martín-Nieto, and Nicolás Cuenca
November 2022, International journal of molecular sciences,
Laura Fernández-Sánchez, and Pedro Lax, and Isabel Pinilla, and José Martín-Nieto, and Nicolás Cuenca
January 2014, Frontiers in neuroscience,
Laura Fernández-Sánchez, and Pedro Lax, and Isabel Pinilla, and José Martín-Nieto, and Nicolás Cuenca
August 2020, Antioxidants (Basel, Switzerland),
Copied contents to your clipboard!